Abstract
ObjectiveTo evaluate the risk of serious adverse events among patients with type 2 diabetes mellitus initiating saxagliptin compared with oral antidiabetic drugs (OADs) in classes other than dipeptidyl peptidase-4 (DPP-4)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have